Contact this trialFirst, we need to learn more about you.
Multi-kinase inhibitor
Sorafenib for Gastrointestinal Stromal Tumor
Recruiting1 awardPhase 2
New York, New York
This trial is studying sorafenib for treating patients with gastrointestinal stromal tumor that progressed after treatment with imatinib and sunitinib.
Fill-in a few details and create your profileHaving a profile will help us send you recommended trials and speed up your application in the future.
We will keep your details privateWe won’t share unless you give us permission. By completing this form you agree to our privacy policy
Get in touch with the study teamWe’ll send your responses to the study team and help you to setup your first screening. This is not the start of informed consent. Screening happens between you and the trial.